title: Comparison between adult endocarditis due to beta-hemolytic streptococci (serogroups A, B, C, and G) and Streptococcus milleri: a multicenter study in France.
abstract: BACKGROUND
  Limited data exist on infective endocarditis (IE) due to Streptococcus milleri (Sm) or beta-hemolytic streptococci (BHS). Because BHS and Sm share some physiologic and pathogenic properties, we wondered whether IE caused by these streptococci might present similarities.
  
  
  METHODS
  Through a nationwide retrospective study in France, the medical and microbiologic charts of adults with definite Sm or BHS IE observed between January 1, 1991, and December 31, 1996, in university and general hospitals were reviewed.
  
  
  RESULTS
  Fifty-six patients had BHS IE (33 men and 23 women; median age, 59 years; range, 18-91 years) and 29 had Sm IE (18 men and 11 women; median age, 66 years; range, 37-97 years). The BHS group tended to have more underlying medical conditions (46%) and fewer previous cardiopathies (48%) than the Sm group (28% and 71%, respectively). Multivariate analysis showed that a longer median time of IE evolution before diagnosis and identification of the presumed portal of entry were independently associated with Sm IE (P<.01). Extracardiac complications were more frequent in the BHS group (55%) than in the Sm group (39%). Comparison of echocardiographic findings between the 2 groups did not establish any statistically significant difference. Thirty-six patients (64%) in the BHS group and 18 (62%) in the Sm group underwent valve replacement. Overall, mortality was 27% for the BHS group and 14% for the Sm group. For all patients, multivariate analysis retained older age as the only significant risk factor for death (P =.01).
  
  
  CONCLUSIONS
  Compared with Sm IE, BHS IE occurs in younger patients with more underlying diseases and fewer underlying cardiopathies and has a more aggressive presentation and evolution.
authors.affiliation: Fédération de Médicine Interne, Maladies Infectieuses et Tropicales, Hôpital Avicenne, Université Paris-Nord, Bobigny, France.
authors.forename: Agnès
authors.initials: A
authors.lastname: Lefort
authors.forename: Olivier
authors.initials: O
authors.lastname: Lortholary
authors.forename: Philippe
authors.initials: P
authors.lastname: Casassus
authors.forename: Christine
authors.initials: C
authors.lastname: Selton-Suty
authors.forename: Loïc
authors.initials: L
authors.lastname: Guillevin
authors.forename: Jean-Luc
authors.initials: JL
authors.lastname: Mainardi
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D004452:Echocardiography; D004697:Endocarditis, Bacterial / Q000150:complications / Q000000981:diagnostic imaging / Q000453:epidemiology* / Q000382:microbiology*; D005260:Female; D005602:France / Q000453:epidemiology; D006769:Hospitals, General / Q000706:statistics & numerical data; D006785:Hospitals, University / Q000706:statistics & numerical data; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012307:Risk Factors; D012720:Severity of Illness Index; D013290:Streptococcal Infections / Q000150:complications / Q000000981:diagnostic imaging / Q000453:epidemiology* / Q000382:microbiology*; D013291:Streptococcus / Q000145:classification / Q000302:isolation & purification / Q000472:pathogenicity; D013292:Streptococcus agalactiae; D034364:Streptococcus milleri Group / Q000302:isolation & purification / Q000472:pathogenicity; D013297:Streptococcus pyogenes; D011795:Surveys and Questionnaires